How a Biosimilar Could Expand Choices for Ulcerative Colitis TherapyBusiness PenAugust 31, 2026 August 31, 2026 The U.S. Food and Drug Administration has begun reviewing a new application that could bring a more convenient version of a widely used gut-inflammation drug...